The Macrophage Migration Inhibitory Factor (MIF) Promoter Polymorphisms (rs3063368, rs755622) Predict Acute Kidney Injury and Death after Cardiac Surgery
暂无分享,去创建一个
D. Leaf | P. Meybohm | D. Wieczorek | J. Bernhagen | L. Leng | R. Bucala | A. Zarbock | S. Mucha | K. Zacharowski | C. Stoppe | H. Surowy | G. Marx | H. Lüdecke | Luisa Averdunk | K. Fehnle | On Behalf Of The RIPHeart Study Collaborators | L. Averdunk
[1] Tsong Huey Sophia Chew,et al. Association of genetic polymorphisms with acute kidney injury after cardiac surgery in a Southeast Asian population , 2019, PloS one.
[2] Maurice H. T. Ling,et al. Advancing Personalized Medicine Through the Application of Whole Exome Sequencing and Big Data Analytics , 2019, Front. Genet..
[3] Ryan L. Collins,et al. The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.
[4] D. Hasenclever,et al. Genome-wide association study of myocardial infarction, atrial fibrillation, acute stroke, acute kidney injury and delirium after cardiac surgery – a sub-analysis of the RIPHeart-Study , 2019, BMC Cardiovascular Disorders.
[5] A. Ozsoy,et al. Influence of the MIF polymorphism −173G > C on Turkish postmenopausal women with osteoporosis , 2018, Zeitschrift für Rheumatologie.
[6] S. Vishwakarma,et al. Association of CD14 and macrophage migration inhibitory factor gene polymorphisms with inflammatory microRNAs expression levels in ankylosing spondylitis and polyarthralgia , 2018, International journal of immunogenetics.
[7] Aihua Liu,et al. CATT polymorphism in MIF gene promoter is closely related to human pulmonary tuberculosis in a southwestern China population , 2018, International journal of immunopathology and pharmacology.
[8] P. Boor,et al. The protective role of macrophage migration inhibitory factor in acute kidney injury after cardiac surgery , 2018, Science Translational Medicine.
[9] P. Boor,et al. Macrophage Migration Inhibitory Factor Limits Renal Inflammation and Fibrosis by Counteracting Tubular Cell Cycle Arrest. , 2017, Journal of the American Society of Nephrology : JASN.
[10] Y. H. Lee,et al. Circulating macrophage migration inhibitory factor levels and its polymorphisms in systemic lupus erythematosus: A meta-analysis. , 2017, Cellular and Molecular Biology.
[11] D. Bourdette,et al. MIF and D-DT are potential disease severity modifiers in male MS subjects , 2017, Proceedings of the National Academy of Sciences.
[12] L. Leng,et al. MIF-2/D-DT enhances proximal tubular cell regeneration through SLPI- and ATF4-dependent mechanisms. , 2017, American journal of physiology. Renal physiology.
[13] E. Miller,et al. Comparison of macrophage migration inhibitory factor and neutrophil gelatinase-associated lipocalin-2 to predict acute kidney injury after liver transplantation: An observational pilot study , 2017, PloS one.
[14] L. Leng,et al. MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics , 2017, Expert opinion on therapeutic targets.
[15] Ji-fei Tang,et al. Macrophage migration inhibitory factor promoter polymorphisms (−794 CATT5–8): Relationship with soluble MIF levels in coronary atherosclerotic disease subjects , 2017, BMC Cardiovascular Disorders.
[16] J. Bernhagen,et al. MIF allele-dependent regulation of the MIF coreceptor CD44 and role in rheumatoid arthritis , 2016, Proceedings of the National Academy of Sciences.
[17] D. Leaf,et al. Length Polymorphisms in Heme Oxygenase-1 and AKI after Cardiac Surgery. , 2016, Journal of the American Society of Nephrology : JASN.
[18] Weiling Fu,et al. Transcription factor ICBP90 regulates the MIF promoter and immune susceptibility locus. , 2016, The Journal of clinical investigation.
[19] R. Rossaint,et al. Interaction of MIF Family Proteins in Myocardial Ischemia/Reperfusion Damage and Their Influence on Clinical Outcome of Cardiac Surgery Patients , 2015, Antioxidants & redox signaling.
[20] D. Hasenclever,et al. A Multicenter Trial of Remote Ischemic Preconditioning for Heart Surgery. , 2015, The New England journal of medicine.
[21] J. Muñóz-Valle,et al. Macrophage Migration Inhibitory Factor Promoter Polymorphisms (−794 CATT5–8 and −173 G>C): Relationship with mRNA Expression and Soluble MIF Levels in Young Obese Subjects , 2015, Disease markers.
[22] Peng Guo,et al. Macrophage immigration inhibitory factor promotes cell proliferation and inhibits apoptosis of cervical adenocarcinoma , 2015, Tumor Biology.
[23] Yonggang Zhang,et al. Macrophage migration inhibitory factor –173G/C gene polymorphism increases the risk of renal disease: A meta‐analysis , 2015, Nephrology.
[24] S. Ryter,et al. Oxidative stress and autophagy: Crucial modulators of kidney injury , 2015, Redox biology.
[25] J. Muñóz-Valle,et al. Association between the −794 (CATT)5–8 MIF Gene Polymorphism and Susceptibility to Acute Coronary Syndrome in a Western Mexican Population , 2014, Journal of Immunology Research.
[26] J. Bernhagen,et al. Macrophage migration inhibitory factor in myocardial ischaemia/reperfusion injury. , 2014, Cardiovascular research.
[27] Yung-Yee Chang,et al. Association between MIF gene polymorphisms and carotid artery atherosclerosis. , 2013, Biochemical and biophysical research communications.
[28] Sushrut S Waikar,et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[29] P. Kimmel,et al. Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. , 2012, Kidney international.
[30] R. Rossaint,et al. High Postoperative Blood Levels of Macrophage Migration Inhibitory Factor Are Associated with Less Organ Dysfunction in Patients after Cardiac Surgery , 2012, Molecular medicine.
[31] É. Azoulay,et al. A Multicentre Study of Acute Kidney Injury in Severe Sepsis and Septic Shock: Association with Inflammatory Phenotype and HLA Genotype , 2012, PloS one.
[32] Ruth R. Montgomery,et al. Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus. , 2011, Arthritis and rheumatism.
[33] Douglas Wood,et al. Shortage of Cardiothoracic Surgeons Is Likely by 2020 , 2009, Circulation.
[34] J. Carrero,et al. Elevated Serum Macrophage Migration Inhibitory Factor (MIF) Concentrations in Chronic Kidney Disease (CKD) Are Associated with Markers of Oxidative Stress and Endothelial Activation , 2009, Molecular medicine.
[35] C. Meisinger,et al. Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. , 2008, Atherosclerosis.
[36] D. Cohen,et al. The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program. , 2008, The Annals of thoracic surgery.
[37] C. Meisinger,et al. Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case–Cohort Study, 1984–2002 , 2008, Diabetologia.
[38] J. Alpert,et al. Universal definition of myocardial infarction. , 2007, European heart journal.
[39] M. González-Gay,et al. Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus , 2006, Genes and Immunity.
[40] Sung-Hwan Park,et al. Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies , 2005, Nucleic acids research.
[41] P. Gregersen,et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis , 2002, Genes and Immunity.
[42] John David,et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[43] G. Bernard,et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). , 2001, JAMA.
[44] R. Atkins,et al. URINE MACROPHAGE MIGRATION INHIBITORY FACTOR CONCENTRATIONS AS A DIAGNOSTIC TOOL IN HUMAN RENAL ALLOGRAFT REJECTION1 , 2001, Transplantation.
[45] K. Yasuda,et al. An increase in macrophage migration inhibitory factor release in patients with cardiopulmonary bypass surgery , 2000, Surgery Today.
[46] R. Salamon,et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[47] M. Pessin,et al. Serial Assessment of Acute Stroke Using the NIH Stroke Scale , 1994, Stroke.
[48] R. Atkins,et al. Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis. , 2002, Journal of the American Society of Nephrology : JASN.
[49] R. Atkins,et al. Migration inhibitory factor expression in experimentally induced endotoxemia. , 1997, The American journal of pathology.